Consistent with these results, all 13 ERBB2-positive breast tumors (Additional file 1: Table S1) that we tested had 3- and 4-fold higher levels of STARD10 and ERBB2 mRNA, respectively, compared to normal breast tissue (Fig. 1b, left panel). Here, STARD10 is linked to breast neoplasm.